Survival In Patients With Metastatic Breast Cancer Improved By Nonhormonal Treatment Regimens

News — By on December 10, 2008 at 3:00 am

Nonhormonal treatment regimens, including anthracycline-based regimens and taxanes, have improved overall survival in women with advanced (metastatic or recurrent inoperable) breast cancer over the last 35 years, according to a systematic review published December 9 in the Journal of the National Cancer Institute. Numerous regimens have been tested in advanced breast cancer.

Please read the complete article and let us know what you think below.

Leave a Reply

Trackbacks

Leave a Trackback